Safe Prescribing in Children Flashcards
Why is paediatrics a high risk prescribing area?
- Children are not small adults with respect to pharmacokinetics and pharmacodynamics of drugs.
- More prone to drug errors which can have serious consequences.
- Often have to manipulate adult formulations due to lack of syrups etc on market.
- Licencing issues – may not be licenced for use in children therefore potential lack of evidence for safe use.
- Calculations galore!
- Missed doses are a common problem due to poor adherence.
What are the common problems with calculations when prescribing for children?
- 10 fold and 100 fold overdoses common.
- mg/Kg dose confused with mg/Kg/day.
- Confusion between doses expressed as mgs or mLs.
- Confusion between units as often dealing with much smaller doses - milligrams/ micrograms/ nanograms.
Define the following terms:
- Neonate
- Infant
- Child
- Adolescent
What are the legal issues surrounding licensing in paediatric prescribing?
- Medicine may be:
- Licensed but not for use in children.
- Licensed in children but used outwith the license - this is ‘off-label’ prescribing.
- Not licensed in the UK.
- Prescribing unlicensed medicines or medicines outside their marketing authorisation alters (and probably increases) the prescriber’s professional responsibility and potential liability.
- The prescriber must be able to justify and feel competent in using such medicines in that particular age group or condition.
Describe how absorption varies according to route of administration in children.
-
Oral
- At birth – 3 years : reduced gastric acids, increased gastric emptying. Leads to e.g. Increased oral absorption of penicillins and reduced oral absorption of phenobarbitone, phenytoin, rifampicin in infants.
- Over 3 – similar to adults.
-
Intramuscular
- Erratic absorption.
- Painful due to small muscle mass.
- Tends to be ineffective in neonates.
- Not to be used for convenience.
- Needle phobia common.
-
Intravenous
- Requires extreme care with dilutions and calculations, need to bear in mind displacement values of drugs.
- Extravasation risk.
- Needle phobia common in children.
-
Percutaneous (topical)
- Enhanced absorption in infants due to:
- Thinner skin, better hydrated, increased surface area.
- May be harmful as more drug absorbed - eg steroids, chlorhexidine – increased side-effects.
-
Rectal
- Variation in blood supply to rectum – may yield variable response.
- Useful in vomiting or if reluctant to take.
- Useful for some drugs like diazepam, paracetamol.
-
Buccal
- Good route for some drugs as doesn’t require swallowing e.g. midazolam.
What are the factors which affect drug distribution in children?
- The two main factors influencing drug distribution are body composition and plasma protein binding.
- Protein binding reduced
- Volume of distribution increased
- Result? This may affect the therapeutic window for a drug (i.e. the level in which to aim for of the drug in the body which maximises efficacy and safety).
- Examples:
- Phenytoin therapeutic window lower in neonates.
- Greater doses of water soluble drugs (Penicillin, Gentamicin) on weight / weight basis in newborns.
How does body composition affect drug distribution in children?
- Extracellular fluid is much higher in newborn infants (45%).
- It decreases gradually with increasing age - 25% at 1 year, and 20% by adulthood.
- This means greater doses of water-soluble drugs e.g. penicillin and aminoglycosides on a weight to weight basis are required.
- For example the normal dose of IV Flucloxacillin for a premature neonate is 25mg/kg. If you were to give this to a 70kg adult the dose would be 1.75g but the usual adult dose is a wide range between 0.25g – 2g.
How does protein binding affect drug distribution in children?
- In premature neonates, plasma protein binding is reduced resulting in higher concentrations of free (active) drug.
- This is due to reduced levels of circulating proteins and a reduced ability to bind.
- Therefore these patients have a higher apparent volume of distribution than adults.
- Therapeutic window for phenytoin is lower in neonates than older children due to increased free phenytoin as a proportion of the whole plasma level (aiming for therapeutic level between 6-15mg/L rather than 10-20mg/L).
Describe drug metabolism in children (pre-term and newborns and also older children).
-
Pre-term and newborns have decreased rates of hepatic metabolising capacity due to immature enzyme systems in the liver, particularly oxidation and glucuronidation. This can increase the half-life of some drugs and cause worse side-effects.
- e.g. Increased half-life of diazepam in neonates means it will take longer to excrete so increases side-effect profile.
- Older children (aged 1-9yrs) have greater hepatic metabolising compacity than adults.
- This is thought to be due to the fact that, relative to body size, the liver is larger in children than in adults.
- e.g. theophylline and most anti-epileptics require a larger dose per kilogram than adults to achieve therapeutic plasma concentrations.
- These differences make it difficult to predict correct doses and frequencies of drugs so must be assessed and reviewed frequently to be patient-centered.
Describe drug elimination in the neonate.
- The neonatal liver and kidneys are immature in their capacity to eliminate drugs.
- Both hepatic metabolism and kidney function are reduced in premature babies resulting in increased plasma half-lives of both hepatically and renally cleared drugs.
- This leads to longer plasma half-lives and increased plasma drug concentrations.
- The elimination of a drug from the body is often the most important indices for dosing, so if there is organ (renal or liver) immaturity or impairment there is usually a need to:
- decrease dose OR
- increase dosing interval
What is the advice for prescribing for children with renal impairment.
- Avoid nephrotoxic drugs.
- Examples of problem drugs:
- Opiates
- NSAIDs
- ACE-I
- Immunosuppressants
- Gentamicin
- Creatinine levels change with age, weight and muscle mass and are more difficult to interpret.
- Look at trends for serum creatinine.
- Use local lab references.
- Equation in BNFC to estimate creatinine clearance but consult specialist immediately if impairment is suspected.
- Monitor for symptoms and signs of kidney injury - e.g. oliguria, nephritis, hypoperfusion.
What is the advice for prescribing for children with hepatic impairment?
- Avoid hepatotoxic drugs.
- Problem drugs:
- sedatives
- opioids
- diuretics
- amphotericin
- anticoagulants
- In hypoproteinaemia – extra care with protein bound drugs (e.g. Phenytoin, prednisolone, warfarin, benzodiazepines).
What are the other ‘alarm bell’ drugs in paediatrics?
- Tetracyclines (e.g. doxycycline) – avoid in under 12 years of age – deposited in growing bone and teeth, by binding to calcium, causes staining and occasionally dental hypoplasia).
- Systemic chloramphenicol causing “grey baby syndrome” in newborns if dosing too high.
- Aspirin associated with Reye’s syndrome, not licenced if 16 years of age and under.
What are the considerations when prescribing by the oral route for children?
- Young children find it difficult to swallow tablets or capsules so liquid preparations are usually first choice.
- Use paediatric formulations where available.
- Flavourings, colourings or preservatives may be allergenic.
- Check if child is lactose intolerant, as this is a common excipient in medicines.
- Choose sucrose and alcohol-free (e.g. Phenobarbitone solution - this is alcohol free; whereas elixir contains 38% alcohol).
- Taste, colour and smell? These all affect adherence.
- Different brands may need to be tried depending on if it is strawberry or banana flavour!
- Juice / yoghurt can help mask tastes but drugs should only be added to small quantities of food / drink.
- E.g. added to a teaspoon of yoghurt, not a carton as full dose may not be taken.
- Never add drugs to feeding bottle.
What are the problems with excipients?